What researchers published on IgA-nefropátia
4637 papers, newest first.
Showing 80 of 4637
EsetismertetésNephrotic Syndrome as the Initial Presentation of IgA Nephropathy: A Case Report.Cureus
Challenges in Predicting Estimated Glomerular Filtration Rate Slope Among Adult Patients With IgA Nephropathy: A Population-Based Cohort Study.Canadian journal of kidney health and disease
Corrigendum to Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy.The Journal of clinical investigation
Áttekintés[IgA nephropathy: mucosal immune dysregulation in the terminal ileum and the multi-hit hypothesis].Zhonghua nei ke za zhi
Dynamic sample augmentation discovers gene biomarker for IgA nephropathy.Journal of biological engineering
External validation of the International IgA Nephropathy Prediction Tool in Chinese patients: assessing model performance and the impact of crescents.International urology and nephrology
Clinical Trial of Open-Label Mezagitamab in IgAN: Final 96-Week Results.Kidney international reports
Glomerular C4d Deposition and Persistent Proteinuria in IgA Nephropathy: A Longitudinal Cohort Study.Journal of clinical medicine
EsetismertetésPortal vein thrombosis following targeted-release budesonide in IgA nephropathy and occult liver disease.Clinical kidney journal
Peripheral neutrophil count and kidney outcomes in IgA nephropathy: a retrospective cohort study of 9,030 patients.Frontiers in immunology
Mechanisms Behind the Disease: Understanding the Role of APRIL in IgAN Pathogenesis: A Podcast.Advances in therapy
Efficacy and safety of ambrisentan in IgA nephropathy: real-world evidence.Frontiers in immunology
Evaluating the Long-Term Risk of Kidney Failure in IgAN Using a Real-World Population-Level Cohort From Canada.Kidney international reports
ÁttekintésRole of the complement system in normocomplementemic glomerulopathies.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
IKK-β inhibitor TPCA-1 increases Gd-IgA1 production and decreases C1GALT1 expression in EBV-immortalized B cells from human donors.Frontiers in immunology
Iptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
Iptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
Iptacopan in IgA Nephropathy - Final 24-Month Data. Reply.The New England journal of medicine
Iptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
Clinical significance of the systemic immune-inflammation index as a minimally invasive biomarker reflecting histological activity in IgA nephropathy.Renal failure
Current status and optimization strategies for immunoglobulin a nephropathy management in the Western Region of Chongqing, China: A cross-sectional study.Medicine
Impact of recurrent IgA nephropathy on long-term kidney transplant outcomes: a cohort comparison with autosomal dominant polycystic kidney disease.BMC nephrology
ÁttekintésThe oral-kidney axis in IgA nephropathy: cnm-positive Streptococcus mutans as a microbial trigger.Clinical and experimental nephrology
Up-regulation of CXCR3 on tonsillar T-cells in patients with IgA nephropathy.Clinical and experimental immunology
Pathogenic Gd-IgA1: Redefining the Role of Galactose-Deficient IgA1 in IgA Nephropathy.Journal of the American Society of Nephrology : JASN
Longitudinal changes in proteinuria and kidney function during standard-dose Nefecon treatment in IgA nephropathy: A real-world cohort study.Clinical nephrology
Review of the 10-year kidney biopsy experience of the Szeged Nephrology and Hypertension Center: a comparison of pre-biopsy clinical and biopsy-proven histological diagnoses.Renal failure
ÁttekintésIgA nephropathy: evolving treatment strategies.Jornal brasileiro de nefrologia
EsetismertetésCombined Rituximab and Daratumumab Induces Remission in Refractory Post-Transplant Crescentic IgA Nephropathy.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Perceptions and preferences of self-injectable therapies among adults living with immunoglobulin A nephropathy in the United States: a mixed-methods study.Current medical research and opinion
Sparsentan as First-Line Treatment in IgAN From SPARTAN.Kidney international reports
Rituximab in IgA Nephropathy: The RITA Multicenter Randomized Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation
EsetismertetésPulmonary-Cardiac Involvement in a Patient with IgA Vasculitis.Methodist DeBakey cardiovascular journal
PreprintMucosal Inflammation as a Driver of Gd-IgA1 Production in IgA Nephropathy: Mechanistic Support for Targeted Therapies.bioRxiv : the preprint server for biology
Transcriptomic Identification of Candidate Biomarkers Associated With Vascular Calcification-Related Signaling Pathways in Immunoglobulin A Nephropathy.International journal of genomics
Sibeprenlimab in IgA nephropathy: does the fairy tale continue in phase 3?Annals of translational medicine
EsetismertetésIgA nephropathy in a patient with 17α-hydroxylase/17,20-lyase deficiency caused by the CYP17A1 p. Y329fs mutation: a case report and review.BMC pediatrics
Integrated Transcriptomic Analysis and Experimental Validation Identify ATF3 as a Mesangial Cell-Associated Candidate Regulator in IgA Nephropathy.Journal of inflammation research
Prognostic nutritional index is associated with clinical and histopathological severity in IgA nephropathy.Renal failure
Multi-Omics Analysis Uncovers a Link Between Dysregulated Steroid Hormone Biosynthesis and Pediatric IgA Vasculitis Nephritis.Frontiers in bioscience (Landmark edition)
Automatic Ultrasound Habitat Radiomics for Differentiating Henoch-Schonlein Purpura Nephritis from IgA Nephropathy in Children: A Multicenter Study.Academic radiology
Targeted-Release Budesonide in Chinese Patients with IgA Nephropathy: A Real-World Retrospective Cohort Study.Drug design, development and therapy
Association of tonsillar Pseudomonas identified by 16S rRNA sequencing with clinical remission after tonsillectomy in IgA nephropathy: a machine learning approach.Clinical and experimental nephrology
When red eyes signal glomerular disease: IgA nephropathy presenting as recurrent episcleritis and scleritis.Tropical doctor
Szisztematikus áttekintésCrystalline κ-light-chain proximal tubulopathy in Waldenström macroglobulinemia with an IgA nephropathy pattern: a case report and systematic review.Frontiers in immunology
Lessons from IgA nephropathy: reevaluating the prognosis and management of class I and class II lupus nephritis.Renal failure
ÁttekintésTreatment and practical considerations of IgA nephropathy.Frontiers in medicine
Prognostic value of the neutrophil percentage-to-albumin ratio in patients with IgA nephropathy.BMC nephrology
Association of the Red Blood Cell Distribution Width-to-Albumin Ratio with Renal Outcomes in Chinese Patients with IgA Nephropathy.Journal of clinical medicine
DU-KAN: A Dual-Domain Enhanced Deep-Learning Framework for Digital Pathology-Based Oxford MEST-C Assessment in Pediatric IgA Nephropathy.Bioengineering (Basel, Switzerland)
ÁttekintésChallenges in access to novel IgA nephropathy therapeutics in South Asia.The Lancet regional health. Southeast Asia
Successful Tocilizumab Monotherapy for Steroid-Dependent TAFRO Syndrome with IgA Nephropathy.Turkish journal of haematology : official journal of Turkish Society of Haematology
EsetismertetésPostpartum Triple Allograft Injury with Atypical Hemolytic Uremic Syndrome, Recurrent IgA Nephropathy, and Antibody-Mediated Rejection in a Kidney Retransplant Recipient: A Case Report.Journal of clinical medicine
Pregnancy Outcomes and Long-Term Kidney Function in Women with Primary Glomerulonephritis.Journal of nephrology
Combined and simultaneous use of Nefecon and irbesartan in treatment-naïve primary IgA nephropathy: A retrospective study.Medicine
How I Do It: Recurrent IgA Nephropathy After Transplant-Integrating Emerging Therapies Into Practice.Transplantation
ÁttekintésIgA nephropathy: evolving pathogenic concepts and emerging targeted therapies.Human immunology
Clinical characteristics and prognosis of IgA nephropathy with predominant light chain deposition.Renal failure
ÁttekintésPrimary Mesangial Proliferative Glomerulonephritis: The Forgotten Glomerulopathy.Antibodies (Basel, Switzerland)
ÁttekintésIgA nephropathy: gut microbiome insights and unmet needs in pediatrics.Pediatric nephrology (Berlin, Germany)
ÁttekintésB-cell modulators in immunoglobulin A nephropathy.Frontiers in immunology
Least but not last: Durable C5 silencing for IgA nephropathy.Molecular therapy : the journal of the American Society of Gene Therapy
Peritoneal M2 macrophage-derived extracellular vesicles as a nanotherapeutic for immune-oxidative microenvironment reprogramming in IgA nephropathy.Journal of materials chemistry. B
Ravulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.The New England journal of medicine
Long-term efficacy and safety for the complement factor B inhibitor iptacopan in IgA nephropathy.Kidney international
Outcomes Following Kidney Failure From IgA Nephropathy Compared to Diabetic Kidney Disease and Other Glomerular Diseases.American journal of kidney diseases : the official journal of the National Kidney Foundation
Atacicept in IgA Nephropathy - Phase 3 Trial Final Efficacy Analysis.The New England journal of medicine
Kidney biopsy in the diagnosis of immunoglobulin A nephropathy.Frontiers in medicine
Urinary Biomarker Analysis of the SANCTUARY Trial: Insights into IgA Nephropathy Pathophysiology and Ravulizumab Mechanism of Action.Clinical journal of the American Society of Nephrology : CJASN
Randomizált vizsgálatInterim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy.The New England journal of medicine
Sibeprenlimab in IgA Nephropathy - Final Phase 3 Trial Analysis.The New England journal of medicine
Characterization of IgA, IgA immune complexes and complement depositions in IgA nephropathy using laser microdissection and mass spectrometry.Kidney international
Exosomal C3a initiates the NF-κB-dependent inflammatory axis in IgA nephropathy: a three-phase pilot study integrating clinical, in vivo, and in vitro evidence.Clinical and experimental nephrology
Glomerulonephritis before and after BNT162b2 mRNA vaccine rollout: biopsy-based trends, histopathological spectrum, and temporal associations.International urology and nephrology
Single-cell transcriptomic analysis of the terminal ileum identifies BCMA as a therapeutic target in IgA nephropathy.hLife
[Preliminary evaluation of the efficacy and safety of telitacicept in children with IgA nephropathy].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Correction: Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.Frontiers in pharmacology
Corticosteroids, serum proteins, and the next phase of precision medicine in IgA nephropathy.Clinical kidney journal
Integrating multiple omics approaches to identify AIF1 as a protective factor in IgA nephropathy.Journal of translational autoimmunity
Efficacy and safety of low-dose telitacicept in IgA nephropathy: a real-world study.Clinical kidney journal